Triple

T6004856
Position Surface form Disambiguated ID Type / Status
Subject SOD1 E133684 entity
Predicate hasGeneProduct P3585 FINISHED
Object SOD1 protein E133684 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SOD1 protein | Statement: [SOD1, hasGeneProduct, SOD1 protein]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: SOD1 protein
Context triple: [SOD1, hasGeneProduct, SOD1 protein]
  • A. SOD1 chosen
    SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
  • B. survival motor neuron protein
    Survival motor neuron protein is an essential cellular protein required for the maintenance and function of motor neurons, whose deficiency leads to spinal muscular atrophy.
  • C. C9orf72
    C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
  • D. SMN2
    SMN2 is a human gene that produces a backup form of survival motor neuron protein and is a key therapeutic target in spinal muscular atrophy.
  • E. ALS
    ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and ultimately respiratory failure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasGeneProduct
Context triple: [SOD1, hasGeneProduct, SOD1 protein]
  • A. hasProduct chosen
    Indicates that an entity possesses, offers, or is associated with a particular product.
  • B. targetsGene
    Indicates that one entity is directed toward, acts upon, or is intended to affect a specific gene.
  • C. hasProteinBinding
    Indicates that one entity is capable of physically binding to or interacting specifically with a protein.
  • D. hasProduction
    Indicates that an entity is associated with, or responsible for, the creation or manufacture of another entity or product.
  • E. hasPlasmid
    Indicates that one entity possesses or contains a plasmid associated with it.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00872444c8190bfaf1739dcec765c completed March 22, 2026, 3:19 p.m.
NER Named-entity recognition batch_69c04f10d18081908c351170b7f58d3d completed March 22, 2026, 8:20 p.m.
NED1 Entity disambiguation (via context triple) batch_69c1088f5c84819094e4696c24c4dd79 completed March 23, 2026, 9:31 a.m.
PD Predicate disambiguation batch_69c049e3316c819087ea635fa7ee8472 completed March 22, 2026, 7:58 p.m.
Created at: March 22, 2026, 4:06 p.m.